Improvement of Radioimmunotherapy Using Pretargeting

During the past two decades, considerable research has been devoted to radionuclide therapy using radiolabeled monoclonal antibodies and receptor binding agents. Conventional radioimmunotherapy (RIT) is now an established and important tool in the treatment of hematologic malignancies such as Non-Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Frampas, Eric, Rousseau, Caroline, Bodet-Milin, Caroline, Barbet, Jacques, Chatal, Jean-Francois, Kraeber-Bodéré, Françoise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687199/
https://www.ncbi.nlm.nih.gov/pubmed/23802097
http://dx.doi.org/10.3389/fonc.2013.00159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687199/
https://www.ncbi.nlm.nih.gov/pubmed/23802097
http://dx.doi.org/10.3389/fonc.2013.00159

Ejemplares similares